$15.62
-0.08-0.51%
Pre-Market: 5:31 AM EDT
Comments
Loading...
Latest Teva Pharmaceutical Indus Stock News | NYSE:TEVA | Benzinga
Get the latest news on Teva Pharmaceutical Indus stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Teva Pharmaceutical Indus performance
Categories: All
Friday, March 21, 2025
Friday, March 07, 2025
Thursday, March 06, 2025
Tuesday, February 25, 2025
Monday, February 24, 2025
Friday, February 21, 2025
Tuesday, February 18, 2025
Sunday, February 16, 2025
Monday, February 10, 2025
Sunday, February 02, 2025
Thursday, January 30, 2025
Wednesday, January 29, 2025
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Crude Oil Down 1.5%; Teva Pharmaceutical Shares Plummet
- Stocks Tick Down Ahead Of Fed Meeting, Nvidia Jitters Resume, Trump Media Rallies: What's Driving Markets Wednesday?
- Nasdaq Down Over 100 Points; Corning Posts Upbeat Earnings
- Teva Pharmaceutical Stock Falls On Q4 Earnings: What's Going On?
- Manhattan Associates, LendingClub And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- Teva Sees FY25 Revenue $16.8B-$17.4B Vs $17.0...
- Teva Pharmaceuticals shares are trading lower...
- Teva Pharmaceutical Indus Q4 2024 Adj EPS $0....
- Earnings Scheduled For January 29, 2025
Tuesday, January 28, 2025
Monday, January 27, 2025
Thursday, January 23, 2025
Wednesday, January 22, 2025
Friday, January 17, 2025
- Teva Challenges Drug Price Law's Impact On Innovation, Generics
- Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
- Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
- 'Ozempic Is In The Next Round Of Medicare Dru...
- Piper Sandler Maintains Overweight on Teva Ph...